1. World Health Organization. Report: global tuberculosis control. 2010. Geneva: World Health Organization.
2. Statistics Korea [Internet]. c1996. cited 2011 Nov 17. Daejeon: Statistics Korea;Available from:
http://kostat.go.kr/.
3. Korean National Tuberculosis Association [Internet]. cited 2011 Nov 17. Seoul: Korean National Tuberculosis Association;Available from:
http://www.knta.or.kr/.
4. Harries AD, Hargreaves NJ, Gausi F, Kwanjana JH, Salaniponi FM. High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis. 2001. 5:1000–1005.
5. Davis CE Jr, Carpenter JL, McAllister CK, Matthews J, Bush BA, Ognibene AJ. Tuberculosis. Cause of death in antibiotic era. Chest. 1985. 88:726–729.
6. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997. 336:243–250.
7. Lim WS, Macfarlane JT, Boswell TC, Harrison TG, Rose D, Leinonen M, et al. Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax. 2001. 56:296–301.
8. Hong YP. Hong YP, Kim SJ, editors. Chapter 13. Clinical diagnostic classification. Tuberculosis. 1993. 4th ed. Seoul: The Korean Academy of Tuberculosis and Respiratory Diseases;142–143.
9. Nguyen LT, Hamilton CD, Xia Q, Stout JE. Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003. Int J Tuberc Lung Dis. 2011. 15:257–262.
10. Nahid P, Jarlsberg LG, Rudoy I, de Jong BC, Unger A, Kawamura LM, et al. Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis. BMC Infect Dis. 2011. 11:1.
11. Low S, Ang LW, Cutter J, James L, Chee CB, Wang YT, et al. Mortality among tuberculosis patients on treatment in Singapore. Int J Tuberc Lung Dis. 2009. 13:328–334.
12. Lefebvre N, Falzon D. Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J. 2008. 31:1256–1260.
13. Meintjes G, Schoeman H, Morroni C, Wilson D, Maartens G. Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: a cross-sectional study. BMC Infect Dis. 2008. 8:72.
14. Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS. 2001. 15:143–152.
15. Shin SR, Kim CH, Kim SE, Park YB, Lee JY, Mo EK, et al. Predictors on in-hospital mortality following in-hospital diagnosis of tuberculosis. Tuberc Respir Dis. 2006. 61:233–238.
16. Rao VK, Iademarco EP, Fraser VJ, Kollef MH. The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. Chest. 1998. 114:1244–1252.
17. Rasmussen TA, Søgaard OS, Camara C, Andersen PL, Wejse C. Serum procalcitonin in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2011. 15:251–256.
18. DeLegge MH, Drake LM. Nutritional assessment. Gastroenterol Clin North Am. 2007. 36:1–22.
19. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol. 1997. 50:693–703.
20. Zahar JR, Azoulay E, Klement E, De Lassence A, Lucet JC, Regnier B, et al. Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Med. 2001. 27:513–520.
21. Kang JY, Kim MS, Kim JS, Kang HH, Kim SS, Kim YH, et al. Clinical characteristics and prognostic factors in patients with pulmonary tuberculosis admitted to intensive care units. Tuberc Respir Dis. 2010. 68:259–266.